Diabetes Type 2 Clinical Trials 2023

Diabetes Type 2 Clinical Trials 2023

Diabetes Type 2 research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in diabetes type 2 clinical trials today.

Diabetes Type Clinical Trials 2023

Here are the 6 most popular medical studies for diabetes type 2

Popular filter options for diabetes type 2 trials

Type 2 Diabetes Clinical Trials

View 98 Type 2 Diabetes medical studies.

T2D Clinical Trials

View 98 T2D medical studies.

Phase 3 Diabetes Type 2 Clinical Trials

View 98 phase 3 diabetes type 2 medical studies.

Diabetes Type 2 Clinical Trials With No Placebo

View 98 diabetes type 2 medical studies that do not have a placebo group.

View More Diabetes Type 2 Trials

See another 81 many medical studies focused on diabetes type 2.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to diabetes type 2

What are the top hospitals conducting diabetes type 2 research?

When it comes to advancing treatment options for individuals living with type 2 diabetes, several leading hospitals are making significant contributions through their clinical trials. In Los Angeles, the University of Southern California takes a proactive approach with three ongoing trials dedicated to type 2 diabetes, building upon their track record of six completed studies since initiating research in this area back in 2013. Meanwhile, on the opposite coast in Boston, the Joslin Diabetes Center is also at the forefront of innovative therapies. With two active trials and an impressive history of 33 previous studies focusing on type 2 diabetes since their first trial in 2001, they continue to push boundaries for improved management and care.

Additionally joining this effort are Novo Nordisk Investigational Sites located in La Mesa and Los Angeles respectively. These sites have been actively involved in conducting essential research by running two current clinical trials each related specifically to type 2 diabetes while having accomplished twelve past investigations starting as early as2003 and fifty-seven extensive explorations beginning from year2002 consecutively.In another location within San Diego lies yet another Novo Nordisk Investigational Site conducting similar pioneering endeavors; they currently maintain two ongoing tests concerning type- II-diabetes.With thirty-five prior projects undertaken relating especially towards managing this condition which initiated from year2006 itself.

These esteemed institutions demonstrate not only commitment but also collaboration towards finding more effective treatments for those affected by type 2 diabetes. By participating in these clinical trials, patients help pave the way for future breakthroughs that hold promise for millions living with this chronic disease worldwide

Which are the best cities for diabetes type 2 clinical trials?

When it comes to diabetes type 2 clinical trials, several cities across the United States are at the forefront of research and innovation. San Antonio, Texas emerges as a top destination with its eight ongoing trials investigating treatments like Empagliflozin, Mifepristone 300 mg, Semaglutide, and lifestyle interventions. Los Angeles, California follows closely behind with seven active studies focusing on therapies such as Mifepristone 300 mg and Peer Support Groups. Atlanta, Georgia; Austin, Texas; and Boston Massachusetts, California follows closely behind with seven active studies focusing on therapies such as Mifepristone 300 mg and Peer Support Groups. Atlanta, Georgia; Austin, Texas; and Boston Massachusetts also contribute significantly to diabetes type 2 research through their respective clinical trials exploring various treatment options for improved management and understanding of this chronic condition.

Which are the top treatments for diabetes type 2 being explored in clinical trials?

Clinical trials are actively exploring potential treatments for type 2 diabetes, with two notable contenders in the spotlight. Semaglutide has emerged as a leading candidate, currently undergoing four active trials and accumulating a total of 58 trials dedicated to diabetes type 2r type 2 diabetes, with two notable contenders in the spotlight. Semaglutide has emerged as a leading candidate, currently undergoing four active trials and accumulating a total of 58 trials dedicated to diabetes type 2 since its debut in 2017. Another innovative approach is the Community Health Navigator Program, which aims to provide support and guidance through three ongoing clinical trials. Introduced recently in 2021, this program shows promise as an alternative avenue for managing and treating type 2 diabetes. As research progresses, these developments offer hope for improving the lives of individuals living with this chronic condition.

What are the most recent clinical trials for diabetes type 2?

Recent clinical trials offer promising insights into the management of type 2 diabetes. The MANAGe-DM trial, currently in Phase 3, presents a potential breakthrough in the field. Another noteworthy study is Active, which has shown positive results in Phase 1 and Phase 4 for individuals with diabetes type 2f type 2 diabetes. The MANAGe-DM trial, currently in Phase 3, presents a potential breakthrough in the field. Another noteworthy study is Active, which has shown positive results in Phase 1 and Phase 4 for individuals with diabetes type 2. Additionally, there are two ongoing trials involving semaglutide and mifepristone that aim to evaluate their efficacy when combined with lifestyle interventions or used as standalone treatments for type 2 diabetes patients. These studies represent significant advancements toward improving treatment options and outcomes for individuals living with this condition.

What diabetes type 2 clinical trials were recently completed?

Several recent clinical trials have made significant strides in the field of diabetes type 2. In August 2022, Pfizer successfully completed a trial for PF-07081532, while Glyscend, Inc.'s trial investigating GLY-200 also concluded during the same month. Vanderbilt University Medical Center's study on L-Lysine came to an end in March 2022, along with Gan and Lee Pharmaceuticals' trial testing GZR-18. Other notable trials include Altimmune, Inc.'s completion of their study on ALT-801 in February 2022 and Sanofi's trial evaluating Insulin glargine/Lixisenatide in January 2022. These pioneering efforts by various organizations highlight the ongoing commitment to advancing treatments for patients living with diabetes type 2.